During the six months after admission to the study, 72% of non-ambulatory people after stroke who received treadmill walking with body weight support achieved independent walking compared with 60% of the control group who received assisted overground walking (Ada et al 2010). It has been found that treadmill walking is biomechanically different to overground walking (Van Ingen Schenau 1980). Less well known is whether these differences are important in training walking after stroke. Hesse (2008) reported that some clinicians were reluctant to use treadmill walking
JQ1 clinical trial as an intervention after stroke for fear patients would practise abnormal walking patterns. Others have noted that treadmill walking may not be comparable to overground walking (Collett et al 2007). Treadmill walking with body weight support not only needs to be shown to be effective, but it also needs to be shown not to be deleterious buy Rigosertib in terms of the quality of walking. This would then remove potential barriers to widespread implementation of the intervention in stroke rehabilitation. The MOBILISE trial therefore included secondary outcome measures, such as walking speed and stride length, that reflected walking quality. Treadmill walking may also have potential benefits from the extra practice that treadmill walking with body weight support affords.
For example, capacity in the form of being able to walk further may be enhanced as a result of the additional practice. Furthermore, confidence to walk and participate in the community may be enhanced. Therefore, other secondary outcome measures included were walking capacity, perception of walking ability, community participation and falls. The purpose of this paper is to report the analysis of the secondary outcomes from the MOBILISE trial. Therefore, the specific research questions were: 1. Is treadmill walking with body weight support during inpatient rehabilitation detrimental to walking quality compared with Urease assisted overground walking? Answering these questions should facilitate the translation of evidence into practice. An analysis of secondary
outcomes of the MOBILISE trial was performed. The MOBILISE trial was a prospective, multicentre, randomised trial comparing treadmill walking with body weight support versus assisted overground walking in non-ambulatory people after stroke. Non-ambulatory stroke patients were screened by an independent recruiter and randomly allocated into either an experimental group or a control group. Randomisation was stratified by centre and severity using randomly permuted blocks of four or six patients. Sitting balance (Item 3) of the Motor Assessment Scale for Stroke was used to stratify severity. Those with scores 0–3 were randomised separately to those with scores 4–6. The allocation sequence was computer-generated before commencement of the study and centrally located.